Sigma Planning Corp Syndax Pharmaceuticals Inc Transaction History

Sigma Planning Corp

$3.22 Billion
Q3 2024

A detailed history of Sigma Planning Corp transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Sigma Planning Corp holds 18,735 shares of SNDX stock, worth $245,053. This represents 0.01% of its overall portfolio holdings.

Number of Shares

18,735

Previous 18,935 1.06%

Holding current value

$245,053

Previous $388,000 7.22%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$17.93 - $24.81 $3,586 - $4,962	-200 Reduced 1.06%	18,735 $360,000
Q2 2024 Aug 05, 2024	SELL	$18.82 - $23.79 $16,938 - $21,411	-900 Reduced 4.54%	18,935 $388,000
Q1 2024 May 01, 2024	BUY	$19.71 - $24.57 $390,947 - $487,345	19,835 New	19,835 $472,000
Q3 2023 Nov 06, 2023	SELL	$14.52 - $21.77 $145 - $217	-10 Reduced 0.05%	20,750 $301,000
Q2 2023 Aug 01, 2023	SELL	$19.35 - $22.31 $48,181 - $55,551	-2,490 Reduced 10.71%	20,760 $434,000
Q1 2023 May 05, 2023	SELL	$20.66 - $28.98 $55,575 - $77,956	-2,690 Reduced 10.37%	23,250 $491,000
Q4 2022 Jan 24, 2023	BUY	$20.64 - $26.24 $6,192 - $7,871	300 Added 1.17%	25,940 $0
Q3 2022 Nov 10, 2022	BUY	$18.51 - $24.79 $33,318 - $44,622	1,800 Added 7.55%	25,640 $616,000
Q2 2022 Aug 11, 2022	SELL	$13.64 - $19.48 $10,230 - $14,610	-750 Reduced 3.05%	23,840 $459,000
Q4 2021 Feb 02, 2022	SELL	$15.23 - $22.47 $3,046 - $4,494	-200 Reduced 0.81%	24,590 $538,000
Q3 2021 Oct 28, 2021	SELL	$13.87 - $19.8 $6,241 - $8,910	-450 Reduced 1.78%	24,790 $474,000
Q2 2021 Aug 13, 2021	SELL	$13.42 - $25.18 $2,684 - $5,036	-200 Reduced 0.79%	25,240 $433,000
Q1 2021 May 06, 2021	SELL	$19.28 - $24.59 $1,638 - $2,090	-85 Reduced 0.33%	25,440 $569,000
Q4 2020 Feb 09, 2021	SELL	$15.1 - $26.44 $9,060 - $15,864	-600 Reduced 2.3%	25,525 $568,000
Q3 2020 Nov 03, 2020	BUY	$13.39 - $17.48 $1,339 - $1,748	100 Added 0.38%	26,125 $386,000
Q2 2020 Jul 31, 2020	BUY	$8.94 - $20.98 $232,663 - $546,004	26,025 New	26,025 $386,000
Q3 2019 Nov 01, 2019	SELL	$7.47 - $10.76 $91,731 - $132,132	-12,280 Closed	0 $0
Q2 2019 Aug 01, 2019	BUY	$4.9 - $9.31 $60,172 - $114,326	12,280 New	12,280 $114,000

Others Institutions Holding SNDX

# of Institutions

228

Shares Held

88.4M

Call Options Held

1.01M

Put Options Held

692K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $740M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sigma Planning Corp, based on Form 13F filings with the SEC.

News

Stay updated on Sigma Planning Corp with notifications on news.

Account

Sigma Planning Corp Syndax Pharmaceuticals Inc Transaction History